WO2007002106A3 - Methods for the detection of colorectal cancer - Google Patents

Methods for the detection of colorectal cancer Download PDF

Info

Publication number
WO2007002106A3
WO2007002106A3 PCT/US2006/024006 US2006024006W WO2007002106A3 WO 2007002106 A3 WO2007002106 A3 WO 2007002106A3 US 2006024006 W US2006024006 W US 2006024006W WO 2007002106 A3 WO2007002106 A3 WO 2007002106A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
methods
cell
detection
free protein
Prior art date
Application number
PCT/US2006/024006
Other languages
French (fr)
Other versions
WO2007002106A2 (en
Inventor
Sadanand Gite
Jennifer Mccullough
Kenneth J Rothschild
Original Assignee
Ambergen Inc
Sadanand Gite
Jennifer Mccullough
Kenneth J Rothschild
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambergen Inc, Sadanand Gite, Jennifer Mccullough, Kenneth J Rothschild filed Critical Ambergen Inc
Priority to US11/922,620 priority Critical patent/US20110045991A1/en
Priority to GB0724881A priority patent/GB2443978A/en
Publication of WO2007002106A2 publication Critical patent/WO2007002106A2/en
Publication of WO2007002106A3 publication Critical patent/WO2007002106A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Abstract

This invention relates to an approach for detection of chain truncating mutations based on the utilization of existing sample collection methods such as FOBT platforms, together with advanced methods for cell-free protein expression. 'When further combined with mass spectrometry, the invention provides the ability to simultaneously detect changes in the amino acid sequence of multiple peptides. In some embodiments, DNA is isolated from a patient fecal sample and specific regions of a gene (i.e., for example, a K- ras gene or an APC gene) are PCR amplified using specifically designed primers that allow translation of encoded peptide fragments in a cell-free protein synthesis system. Nascent proteins are affinity purified and their mass is detected by MALDI-TOF which allows identifying low levels of mutations.
PCT/US2006/024006 2005-06-23 2006-06-21 Methods for the detection of colorectal cancer WO2007002106A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/922,620 US20110045991A1 (en) 2005-06-23 2006-06-21 Methods for the Detection of Colorectal Cancer
GB0724881A GB2443978A (en) 2005-06-23 2006-06-21 Methods for the detection of colorectal cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/159,776 2005-06-23
US11/159,776 US8114587B2 (en) 2005-06-23 2005-06-23 Methods for the detection of colorectal cancer

Publications (2)

Publication Number Publication Date
WO2007002106A2 WO2007002106A2 (en) 2007-01-04
WO2007002106A3 true WO2007002106A3 (en) 2007-12-21

Family

ID=37590007

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/024006 WO2007002106A2 (en) 2005-06-23 2006-06-21 Methods for the detection of colorectal cancer

Country Status (3)

Country Link
US (1) US8114587B2 (en)
GB (1) GB2443978A (en)
WO (1) WO2007002106A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110045991A1 (en) * 2005-06-23 2011-02-24 Sadanand Gite Methods for the Detection of Colorectal Cancer
US8933043B2 (en) * 2005-09-30 2015-01-13 St. Jude Children's Research Hospital Methods for regulation of p53 translation and function
WO2009037266A2 (en) * 2007-09-17 2009-03-26 Universite Louis Pasteur Method for detecting or quantifying a truncating mutation
WO2010064628A1 (en) * 2008-12-05 2010-06-10 オリンパス株式会社 Method for preparing sample containing nucleic acid, solution for preparing sample, and method for analyzing nucleic acid
US20110207143A1 (en) * 2008-12-19 2011-08-25 Abbott Laboratories Diagnostic test for mutations in codons 12-13 of human k-ras
WO2010134245A1 (en) * 2009-05-20 2010-11-25 オリンパス株式会社 Method for collection of nucleic acid derived from mammalian cell, method for analysis of nucleic acid, and kit for collection of feces
WO2011094546A2 (en) * 2010-01-29 2011-08-04 St. Jude Children's Research Hospital Oligonucleotides which inhibit p53 induction in response to cellular stress
US20130012410A1 (en) * 2010-03-29 2013-01-10 Mayo Foundation For Medical Education And Research Methods and materials for detecting colorectal cancer and adenoma
CA2811333C (en) 2010-09-16 2020-05-12 Gen-Probe Incorporated Capture probes immobilizable via l-nucleotide tail
FR2970782A1 (en) * 2011-01-24 2012-07-27 Assist Publ Hopitaux De Paris MULTIFUNCTIONAL DIAGNOSTIC DEVICE
WO2013032839A2 (en) * 2011-09-02 2013-03-07 The Board Of Trustees Of The Leland Stanford Junior University Raman imaging devices and methods of moleclar imaging
WO2014159650A2 (en) 2013-03-14 2014-10-02 Mayo Foundation For Medical Education And Research Detecting neoplasm
EP3839071A1 (en) 2014-03-31 2021-06-23 Mayo Foundation for Medical Education and Research Detecting colorectal neoplasm
US10030272B2 (en) 2015-02-27 2018-07-24 Mayo Foundation For Medical Education And Research Detecting gastrointestinal neoplasms
CA2992790A1 (en) 2015-08-31 2017-03-09 Mayo Foundation For Medical Education And Research Detecting gastric neoplasm
US10370726B2 (en) 2016-04-14 2019-08-06 Mayo Foundation For Medical Education And Research Detecting colorectal neoplasia
CA3020628A1 (en) 2016-04-14 2017-10-19 Mayo Foundation For Medical Education And Research Detecting pancreatic high-grade dysplasia
CA3054836A1 (en) 2017-02-28 2018-09-07 Mayo Foundation For Medical Education And Research Detecting prostate cancer
EP3717644A4 (en) 2017-11-30 2021-12-29 Mayo Foundation for Medical Education and Research Detecting breast cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060068400A1 (en) * 2004-09-30 2006-03-30 Cleator Iain G Device and method for fecal testing

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933594A (en) * 1974-08-16 1976-01-20 Polaroid Corporation Method and device for determining the concentration of a substance in a fluid
US4333734A (en) * 1980-01-18 1982-06-08 Sloan-Kettering Institute For Cancer Research Diagnostic device for fecal occult blood and method of use
US5702913A (en) * 1983-12-21 1997-12-30 Helena Laboratories Corporation Chromgen-reagent test system
US4935342A (en) * 1986-12-01 1990-06-19 Syngene, Inc. Method of isolating and purifying nucleic acids from biological samples
US5217874A (en) * 1989-04-04 1993-06-08 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5192501A (en) * 1989-04-04 1993-03-09 Helena Laboratories Corporation Method of formulating a test ink for a fecal occult blood test product
US5106582A (en) * 1990-12-18 1992-04-21 Smithkline Diagnostics, Inc. Specimen test slide and method of testing for fecal occult blood
US5744306A (en) * 1993-04-19 1998-04-28 Emory University Methods for nucleic acid detection, sequencing, and cloning using exonuclease
US5416025A (en) * 1993-11-29 1995-05-16 Krepinsky; Jiri J. Screening test for early detection of colorectal cancer
US6037465A (en) * 1994-06-14 2000-03-14 Invitek Gmbh Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials
US6413747B1 (en) * 1994-10-03 2002-07-02 Shimadzu Corporation Enhancement of nucleic acid amplification by the addition of a polyamine
GB9518156D0 (en) * 1995-09-06 1995-11-08 Medical Res Council Method of isolating cells
US5747344A (en) * 1996-06-05 1998-05-05 Cleator; Iain G.M. Device and method for screening fecal occult blood specimens
EP0920535B1 (en) * 1996-08-26 2007-11-14 Invitek Gesellschaft für Biotechnik & Biodesign mbH. Method to detect clinically relevant mutations of the dna sequence of ki -ras oncogene, its use and a testkit for early diagnosis of tumours
US6268136B1 (en) * 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
CA2253093A1 (en) * 1998-11-06 2000-05-06 Jiri J. Krepinsky Screening test for early detection of colorectal cancer
US6551780B1 (en) * 2000-03-31 2003-04-22 The Regents Of University Of California Detection of gene mutations or amplifications in melanocytic neoplasms
US7312060B2 (en) * 1999-08-25 2007-12-25 Ambergen, Inc. Methods for the detection, analysis and isolation of nascent proteins
US20080241940A1 (en) * 2004-07-22 2008-10-02 Lastella Vincent P Fecal sampling device and method
US7563598B2 (en) * 2004-07-30 2009-07-21 Ambergen, Inc. Detection of truncation mutations by mass spectrometry

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060068400A1 (en) * 2004-09-30 2006-03-30 Cleator Iain G Device and method for fecal testing

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"Hemoccult II Sensa Product Instructions", October 2002, BECKMAN COULTER INC. *
AHLQUIST ET AL.: "Colorectal Cancer Screening by Detection of Altered Human DNA in Stool: Feasibility of a Multitarget Assay Panel", GASTROENTEROLOGY, vol. 119, 2000, pages 1219 - 1227 *
GITE ET AL.: "A high-throughput nonisotopic protein truncation test", NATURE BIOTECHNOLOGY, vol. 21, 2003, pages 194 - 197 *
SOMERS ET AL.: "Validation of the Point-EXACT method in non-small cell lung carcinomas", CLINICAL CHEMISTRY, vol. 44, no. 7, 1998, pages 1404 - 1409 *
WELLS ET AL.: "Development and application of a polymerase chain reaction assay for the detection and enumeration of bile acid 7 alpha-dehydroxylating bacteria in human feces", CLINICA CHIMICA ACTA, vol. 331, pages 127 - 134 *

Also Published As

Publication number Publication date
US20070003936A1 (en) 2007-01-04
WO2007002106A2 (en) 2007-01-04
GB0724881D0 (en) 2008-02-27
US8114587B2 (en) 2012-02-14
GB2443978A (en) 2008-05-21

Similar Documents

Publication Publication Date Title
WO2007002106A3 (en) Methods for the detection of colorectal cancer
WO2004058990A3 (en) Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
WO2004067779A3 (en) Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
WO2005111241A8 (en) Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
WO2006020775A3 (en) An ultra high-throughput opti-nanopore dna readout platform
EP2474632A3 (en) Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
WO2005005651A3 (en) T cell receptor sequence and method for detecting and treating rheumatoid arthritis
SG134283A1 (en) Biomarkers for liver fibrotic injury
EP1757689A3 (en) Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
WO2004033631A8 (en) Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
Müller et al. Identification of new protein coding sequences and signal peptidase cleavage sites of Helicobacter pylori strain 26695 by proteogenomics
WO2007050705A3 (en) Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof
WO2005118813A3 (en) Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
WO2004081187A8 (en) Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
US20210239708A1 (en) Method to Map Protein Landscapes
WO2002012899A3 (en) Peptides presented by cells
Mitra et al. High level expression of peptides and proteins using cytochrome b5 as a fusion host
WO2004083403A3 (en) Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
WO2008109533A3 (en) Human antibodies that bind multiple irta family proteins, and uses thereof
JP2008061538A (en) METHOD FOR SYNTHESIZING SITE-SPECIFICALLY PHOSPHORYLATED PROTEIN, PHOSPHOSERYL tRNA FOR THE METHOD AND REAGENT KIT FOR PERFORMING THE METHOD
WO2003020887A3 (en) Gene identification
WO2006028565A3 (en) Novel methods for high-throughput genome-wide location analysis
WO2006097336A3 (en) A novel component of the wg/wnt signaling pathway
WO2004033706A3 (en) Nucleic acids encoding duramycin
WO2003093451A3 (en) Transposable elements in rice and methods of use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 0724881

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20060621

WWE Wipo information: entry into national phase

Ref document number: 0724881.8

Country of ref document: GB

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06773630

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 11922620

Country of ref document: US